Shilpee Dutt

New Mehrauli Road
New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.

Journal: Oncotarget

Published: November 07, 2025

Discovery of BEND4 as a novel single-gene prognostic marker and therapeutic target for adverse AML.

Discovery of BEND4 as a novel single-gene prognostic marker and therapeutic target for adverse AML.

Journal: NPJ precision oncology

Published: August 28, 2025

Emerging drug delivery systems to alter tumor immunosuppressive microenvironment: Overcoming the challenges in immunotherapy for glioblastoma.

Emerging drug delivery systems to alter tumor immunosuppressive microenvironment: Overcoming the challenges in immunotherapy for glioblastoma.

Journal: Progress in molecular biology and translational science

Published: October 26, 2024

Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma.

Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma.

Journal: Neuro-oncology

Published: July 18, 2024

Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence.

Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence.

Journal: Oncogene

Published: July 10, 2024

PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair.

PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair.

Journal: Cellular and molecular life sciences : CMLS

Published: July 04, 2024

DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia.

DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia.

Journal: Journal of cell science

Published: December 28, 2023

Biphasic DNA damage and non-canonical replication stress response govern radiation-induced senescence in glioblastoma.

Biphasic DNA damage and non-canonical replication stress response govern radiation-induced senescence in glioblastoma.

Journal: Journal of cell science

Published: November 28, 2023

Epigenetic Regulation Towards Acquired Drug Resistance in Cancer.

Epigenetic Regulation Towards Acquired Drug Resistance in Cancer.

Journal: Sub-cellular biochemistry

Published: October 27, 2022

Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy.

Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy.

Journal: Nanoscale

Published: August 24, 2022

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.

Journal: Drug delivery and translational research

Published: August 01, 2022

Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy.

Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy.

Journal: 3 Biotech

Published: March 08, 2022

Showing 1-12 of 127

Last Updated: 09/26/2026